Palmoplantar Keratoderma Market Trends and Growth Forecast Through 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Palmoplantar Keratoderma Market At The End Of The 2026–2030 Forecast Period?

The palmoplantar keratoderma market size has experienced consistent expansion in recent years. It is projected to increase from $0.88 billion in 2025 to $0.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.9%. The market’s historical development can be linked to an increase in the diagnosis of rare dermatological disorders, the proliferation of dermatology specialty clinics, the broader availability of retinoid therapies, growing patient awareness regarding genetic skin diseases, and enhancements in dermatopathology testing.

The palmoplantar keratoderma market is projected to experience robust expansion over the coming years. Its size is predicted to grow to $1.13 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. This anticipated growth during the forecast period is primarily driven by an increase in targeted dermatology drugs, wider availability of genetic screening access, greater adoption of biologic therapies, a growing number of specialty dermatology pipelines, and broader orphan disease support programs. Key trends expected within this period encompass targeted biologic skin therapies, advanced genetic diagnostic panels, long acting topical formulations, combination retinoid treatment protocols, and the increasing uptake of home-based phototherapy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33255&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Palmoplantar Keratoderma Market?

The increasing occurrence of genetic mutations is projected to drive the expansion of the palmoplantar keratoderma market. These mutations represent alterations or variations in DNA sequences that can elevate an individual’s susceptibility to hereditary conditions and various dermatological disorders. The rising prevalence of genetic mutations is attributed to advancements in genomic sequencing and widespread genetic testing, which facilitate the detection and identification of a growing number of previously unrecognized DNA variations across populations. An increase in genetic mutations contributes to palmoplantar keratoderma by expanding the population with inherited skin-gene alterations, which in turn results in earlier diagnosis and a greater need for specific treatments. For instance, in January 2023, a report published by the National Center for Biotechnology Information (NCBI), a division of the US-based National Library of Medicine (NLM), noted that with approximately 140 million babies born each year, roughly 9.8 billion new human mutations are introduced into the gene pool annually. Therefore, the growing frequency of genetic mutations is fueling the palmoplantar keratoderma market’s expansion.

What Segment Types Make Up The Palmoplantar Keratoderma Market?

The palmoplantar keratoderma market covered in this report is segmented –

1) By Treatment Type: Topical Treatments; Systemic Treatments; Phototherapy; Surgical Interventions

2) By Type: Non Lamellar Keratoderma; Lamellar Keratoderma; Epidermolytic Keratoderma; Palmoplantar Keratoderma With Systemic Involvement

3) By Diagnosis Method: Clinical Examination; Histopathological Examination; Genetic Testing

4) By Patient Type: Pediatric; Adult

5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Topical Treatments: Salicylic Acid Preparations; Urea Creams; Emollients; Retinoid Creams; Corticosteroid Creams

2) By Systemic Treatments: Oral Retinoids; Oral Vitamin D Analogues; Oral Corticosteroids; Oral Immunosuppressants

3) By Phototherapy: Ultraviolet A Therapy; Ultraviolet B Therapy; Psoralen Plus Ultraviolet A Therapy

4) By Surgical Interventions: Excision Surgery; Laser Therapy; Dermabrasion; Skin Grafting

Which Market Trends Are Creating New Opportunities In The Palmoplantar Keratoderma Market?

Major companies operating in the palmoplantar keratoderma market are focusing on conducting clinical trials to develop innovative drugs, such as TRPV3 inhibitors, to provide targeted, disease-modifying treatments that extend beyond symptomatic relief. TRPV3 inhibitors are medications designed to block the TRPV3 ion channel, which helps normalize skin cell growth, strengthen the skin barrier, and reduce the pain and thickening associated with palmoplantar keratoderma. For instance, in June 2024, Kamari Pharma Ltd., a clinical-stage biotechnology company, introduced KM-001, a topical TRPV3 inhibitor, following promising Phase 1b clinical results. KM-001 is formulated as a cream applied twice daily and has demonstrated high safety with no severe adverse events, alongside an overall responder rate of 87% in patients with pachyonychia congenita and punctate palmoplantar keratoderma type 1. Its unique mechanism aids in normalizing skin cell proliferation, enhancing epidermal barrier formation, and alleviating pain in affected patients, offering a disease-modifying alternative to conventional treatments. Kamari Pharma plans to advance KM-001 into Phase 2 trials while also developing KM-023, an oral TRPV3 inhibitor, for broader keratoderma indications.

Which Major Firms Influence Developments In The Palmoplantar Keratoderma Market?

Major companies operating in the palmoplantar keratoderma market are LEO Pharma, Krystal Biotech Inc., and Kamari Pharma.

Read the full palmoplantar keratoderma market report here:

https://www.thebusinessresearchcompany.com/report/palmoplantar-keratoderma-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Palmoplantar Keratoderma Market?

North America was the largest region in the palmoplantar keratoderma market in 2025. Asia – Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the palmoplantar keratoderma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Palmoplantar Keratoderma Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33255&type=smp

Browse Through More Reports Similar to the Global Palmoplantar Keratoderma Market 2026, By The Business Research Company

Actinic Keratosis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-treatment-global-market-report

Palm Kernel Fatty Acids Market Report 2026

https://www.thebusinessresearchcompany.com/report/palm-kernel-fatty-acids-global-market-report

Neurotrophic Keratitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795